刚刚！贝克曼中国区总经理换人！

Core Insights - The article discusses the leadership changes at Beckman Coulter Diagnostics, highlighting the appointment of Andy Chen as the new Global Vice President and General Manager for China, and the continued leadership of Rosa Chen as the President of the China Diagnostics Platform [2][4]. Group 1: Leadership Changes - Andy Chen has been appointed as the Global Vice President and General Manager for Beckman Coulter Diagnostics in China, effective July 1 [2]. - Rosa Chen will focus on the overall operation management of the Danaher China Medical Diagnostics Platform while continuing as its President [2][5]. - Andy Chen will report directly to Rosa Chen and have a dotted line reporting to Kevin O'Reilly, the Global President of Beckman Coulter Diagnostics [3]. Group 2: Background of Andy Chen - Andy Chen joined Danaher in May 2019 and has extensive cross-industry management experience, previously holding key positions at Mettler-Toledo [4]. - Under his leadership, Leica Microsystems China achieved a 25% growth in 2022, with employee engagement increasing from 86% to 90% [4]. - In 2023, he led his team to achieve double-digit growth despite geopolitical uncertainties, with expectations of maintaining high single-digit growth in 2024 [4]. Group 3: Background of Rosa Chen - Rosa Chen joined Danaher in September 2021 and was appointed as the Vice President and General Manager for Beckman Coulter Diagnostics in China in February 2022 [5]. - She has held positions at Johnson & Johnson and Philips, and is actively involved in various medical associations [5]. - Rosa Chen has emphasized "open innovation" and has adapted strategies to support local development in response to policy changes [5].